» Articles » PMID: 33353770

Metabolic Regulation of the Bone Marrow Microenvironment in Leukemia

Overview
Journal Blood Rev
Publisher Elsevier
Specialty Hematology
Date 2020 Dec 23
PMID 33353770
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Most leukemia patients experience little benefit from immunotherapy, in part due to the immunosuppressive bone marrow microenvironment. Various metabolic mechanisms orchestrate the behaviors of immune cells and leukemia cells in the bone marrow microenvironment. Furthermore, leukemia cells regulate the bone marrow microenvironment through metabolism to generate an adequate supply of energy and to escape antitumor immune surveillance. Thus, the targeting of the interaction between leukemia cells and the bone marrow microenvironment provides a new therapeutic avenue. In this review, we describe the concept of the bone marrow microenvironment and several important metabolic processes of leukemia cells within the bone marrow microenvironment, including carbohydrate, lipid, and amino acid metabolism. In addition, we discuss how these metabolic pathways regulate antitumor immunity and reveal potential therapeutic targets.

Citing Articles

Glycolysis and chemoresistance in acute myeloid leukemia.

Yang Y, Pu J, Yang Y Heliyon. 2024; 10(15):e35721.

PMID: 39170140 PMC: 11336864. DOI: 10.1016/j.heliyon.2024.e35721.


Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives.

Li Z, Yao X, Zhang J, Yang J, Ni J, Wang Y Front Immunol. 2024; 15:1403458.

PMID: 39161767 PMC: 11330836. DOI: 10.3389/fimmu.2024.1403458.


Overexpression of Nrf2 in bone marrow mesenchymal stem cells promotes B-cell acute lymphoblastic leukemia cells invasion and extramedullary organ infiltration through stimulation of the SDF-1/CXCR4 axis.

Zheng L, Pan C, Ma D, Shang Q, Hu T, Zhang T Front Pharmacol. 2024; 15:1393482.

PMID: 39081954 PMC: 11286583. DOI: 10.3389/fphar.2024.1393482.


Leukemia and mitophagy: a novel perspective for understanding oncogenesis and resistance.

Liu Y, Ma Z Ann Hematol. 2024; 103(7):2185-2196.

PMID: 38282059 DOI: 10.1007/s00277-024-05635-w.


Progress of research on PD-1/PD-L1 in leukemia.

Cao H, Wu T, Zhou X, Xie S, Sun H, Sun Y Front Immunol. 2023; 14:1265299.

PMID: 37822924 PMC: 10562551. DOI: 10.3389/fimmu.2023.1265299.